Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127355821 | 12735582 | 1 | I | 20160907 | 20160912 | 20160912 | EXP | PHHY2016CO125302 | NOVARTIS | 0.00 | F | Y | 53.00000 | KG | 20160912 | CN | COUNTRY NOT SPECIFIED | CO |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127355821 | 12735582 | 1 | PS | TASIGNA | NILOTINIB | 1 | Oral | 200 MG, TID (THREE TIMES A DAY) | U | 22068 | 200 | MG | CAPSULE | TID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127355821 | 12735582 | 1 | Chronic myeloid leukaemia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127355821 | 12735582 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127355821 | 12735582 | Anaemia | |
| 127355821 | 12735582 | Gastritis | |
| 127355821 | 12735582 | Hyperhidrosis | |
| 127355821 | 12735582 | Incorrect drug administration duration | |
| 127355821 | 12735582 | Pain in extremity | |
| 127355821 | 12735582 | Skin discolouration | |
| 127355821 | 12735582 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |